Backed with a blend of private and Government of Canada investments catalyzed by Grand Challenges Canada, a new Toronto-based company will contribute to a better life for amputees in developing countries. With the new funding, ...
May 27, 2015
0
24
Officials at a life sciences startup based on a Purdue University innovation say their company could help cardiologists improve the diagnosis of heart disease, which the World Health Organization listed as the leading cause ...
Oct 29, 2014
1
0
More than 155,000 people who have taken part in a massive genetic study orchestrated by the U.S. National Institutes of Health (NIH) have already gotten something in return—personalized DNA results that tell them whether ...
Dec 14, 2022
0
1
Griffith University's Institute for Glycomics and Melbourne-based company Paradigm Biopharmaceuticals Limited (ASX: PAR) have reported impressive results from their Phase 2A clinical trials of a new drug candidate to treat ...
Dec 13, 2019
0
0
(HealthDay)—Quality measures play a small but emerging role in physician compensation, according to a report published by the Medical Group Management Association (MGMA).
Jul 11, 2013
0
0
A collaborative report published by researchers at the Irish Longitudinal Study on Aging (TILDA) and ALONE examines issues of loneliness and social isolation in older adults. The report offers fresh insight into the experiences ...
Jul 14, 2020
0
6
US regulators will decide in July whether to approve Qnexa, the first obesity drug in more than a decade, extending the initial deadline by three months, the California-based drug-maker VIVUS said.
Apr 10, 2012
0
0
A whole town celebrated in 2020 when, early in the coronavirus pandemic, Thomasville Regional Medical Center opened, offering state-of-the-art medicine that was previously unavailable in a poor, isolated part of Alabama. ...
May 17, 2022
0
20
Getting personal protective equipment to the frontlines while America fights COVID-19 has more twists and turns than it may seem, but thinking about the supply chain from a disaster recovery perspective can help, a University ...
Apr 20, 2020
0
0
What began in the Dentistry lab of Professor Paul Santerre more than a decade ago is now Interface Biologics Inc. (IBI) - a privately-held company poised to transform the market for medical devices in the United States.
Sep 19, 2012
0
0
